[Form 4] KEWAUNEE SCIENTIFIC CORP /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Kewaunee Scientific director and President/CEO Thomas David Hull III reported a sale of 1,000 shares of the company's common stock on 10/01/2025 at a weighted average price of $43.09 per share, with the reported price range between $43.00 and $43.22. Following the sale, Mr. Hull beneficially owns 38,719 shares. The Form 4 was signed by an attorney-in-fact on 10/02/2025. The filing includes a statement that the reporting person will provide, upon request, the number of shares bought at each separate price within the disclosed range.

Positive

• Timely disclosure of insider transaction via Form 4
• Clear pricing information with weighted average and price range provided
• Post-transaction beneficial ownership is reported (38,719 shares)

Negative

• Insider sale of 1,000 shares by the CEO/director
• No stated reason for the disposition provided in the filing

Insights

Financial Analyst

TL;DR: Insider sale of 1,000 shares reduces CEO/director stake to 38,719 shares; transaction appears routine, not clearly material.

The sale is modest in size relative to typical institutional positions and is disclosed with a weighted average price of $43.09 and a price range of $43.00–$43.22. The filing meets Section 16 disclosure requirements and provides willingness to supply trade-level detail. There is no additional context in the Form 4 about purpose or any derivative transactions, so implications for company operations or outlook are not specified in the filing.

Corporate Governance Expert

TL;DR: The disclosure is compliant and clear; the sale is a standard insider disposition with limited apparent governance concern.

The Form 4 identifies the reporting person as both an officer and director and discloses the post-transaction beneficial ownership of 38,719 shares. Signature by an attorney-in-fact is properly provided. The document contains no indication of undisclosed related-party transactions, option exercises, or changes in control. Based solely on this filing, there are no immediate governance red flags, though investors may seek additional context outside this form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

HULL THOMAS DAVID III

(Last) (First) (Middle)

2700 WEST FRONT STREET

(Street)

STATESVILLE NC 28677

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		S		1,000	D	$43.09(1)	38,719	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reflects the weighted average purchase price of the transactions reported. The price range of such transactions was $43.00 to $43.22. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

Remarks:

	/s/ Donald T. Gardner III, Attorney-in-fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did KEQU insider Thomas David Hull III report on Form 4?

He reported selling 1,000 shares of Kewaunee Scientific common stock on 10/01/2025 at a weighted average price of $43.09, reducing his holdings to 38,719 shares.

What price range was disclosed for the KEQU insider sale?

The filing discloses a price range of $43.00 to $43.22 and a weighted average price of $43.09.

Who signed the Form 4 for the KEQU filing?

The Form 4 was signed by Donald T. Gardner III, attorney-in-fact, on 10/02/2025.

How many shares does the reporting person own after the transaction?

The reporting person beneficially owns 38,719 shares following the reported sale.

Does the Form 4 indicate any derivative or option transactions for KEQU?

No. The filing contains no entries in the derivative securities section; only a non-derivative sale of common stock is reported.